SCHEMBL17112809

SCHEMBL17112809

O=C(c1ccsc1)c1ccc(F)c(Br)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.44
CES1 P23141 2/20 0.44
HDAC1 Q13547 1/20 0.43
LCK P06239 1/20 0.43
FYN P06241 1/20 0.43
DAO P14920 1/20 0.43
HSD17B14 Q9BPX1 2/20 0.40
ALDH1A1 P00352 1/20 0.40
IDO1 P14902 2/20 0.37
TDO2 P48775 2/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
MAOB P27338 1/20 0.36
HPGD P15428 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
PGR P06401 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30817696 0.84 ALDH1A1 (0.52) CES2CES1HSD17B14ALDH1A1IDO1
SCHEMBL7452171 0.78 VNN1 (0.46) CES2CES1LCKFYNDAO
SCHEMBL6961496 0.77 KMT2A (0.47) CES2CES1HDAC1LCKFYN
SCHEMBL7447786 0.77 ALDH1A1 (0.73) ALDH1A1RAB9AHPGDCYP1A2CYP2D6
SCHEMBL2166098 0.76 CES2 (0.71) CES2CES1HDAC1LCKFYN
SCHEMBL7752908 0.76 HPGD (0.58) HDAC1HSD17B14ALDH1A1IDO1TDO2
SCHEMBL6956689 0.75 CES2 (0.54) CES2CES1HDAC1LCKFYN
SCHEMBL17100305 0.75 CES2 (0.54) CES2CES1HDAC1LCKFYN
SCHEMBL17100193 0.73 PARP1 (0.50) CES2CES1HDAC1LCKFYN
SCHEMBL20448559 0.72 SRD5A2 (0.55) CES2CES1HDAC1LCKFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170001990-A1 PIPERIDINE-DIONE DERIVATIVES GENENTECH, INC. (US) 2017-01-05 US disclosed
US-20170001990-A1 PIPERIDINE-DIONE DERIVATIVES GENENTECH, INC. (US) 2017-01-05 US disclosed
WO-2015142903-A2 METHOD OF CONTROLLING LACTATE PRODUCTION WITH PIPERDINE-DIONE DERIVATIVES GENENTECH, INC. (US) 2015-09-24 WO disclosed
WO-2015140133-A1 PIPERIDINE-DIONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2015-09-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170001990-A1 PIPERIDINE-DIONE DERIVATIVES DRD4, ADORA1, ADORA3 CES2 1790/4885CES1 3046/4885HDAC1 1257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.